FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
MSP68 as an effective radiation countermeasure
MSP68 as an effective radiation countermeasure is a funding opportunity from FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH, up to 167500, closing June 30, 2027.
Jun 30, 2027
(334d left)Overview
PROJECT DESCRIPTION: This R21 project aims to develop the pentapeptide MSP68 as a novel and effective medical countermeasure (MCM) to treat the deadly gastrointestinal acute radiation syndrome (GI- ARS) in individuals exposed to high doses of ionizing radiation. We have recently shown that the glycoprotein milk fat…